103573-92-8

Usage

Uses

Used in Pharmaceutical Research and Development:
[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]METHANOL is used as a ligand for specific receptors in the human body, particularly those involved in the central nervous system, for its potential to treat various neurological disorders.
Used in the Treatment of Neurological Disorders:
[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]METHANOL is used as a potential treatment for various neurological disorders, leveraging its interaction with specific receptors in the central nervous system.
Used in the Synthesis of Pharmaceutical Compounds:
[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]METHANOL is used as a building block in the synthesis of other pharmaceutical compounds, contributing to the development of new medications.
Used in Asymmetric Synthesis Reactions:
[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]METHANOL is used as a chiral auxiliary in asymmetric synthesis reactions, playing a crucial role in the production of enantiomerically pure compounds.

InChI:InChI=1/C11H12N2O/c14-8-11-3-1-10(2-4-11)7-13-6-5-12-9-13/h1-6,9,14H,7-8H2

Upstream product

• 288-32-4 1H-imidazole 
• 16473-35-1 4-(hydroxymethyl)benzyl chloride 
• 1642-81-5 p-(chloromethyl)benzoic acid 
• 1201-90-7 ethyl 4-chloromethylbenzoate 
• 56643-80-2 ethyl 4-((1H-imidazol-1-yl)methyl)benzoate 

Downstream Products

• 102432-03-1 4-((1H-imidazol-1-yl)methyl)benzaldehyde 

Relevant academic research and scientific papers

DEGRADABLE IMIDAZOLIUM OLIGOMER AND POLYMER FOR ANTIMICROBIAL APPLICATIONS

The present invention relates to an imidazolium oligomer of formula (I) and an imidazolium oligomer or a polymer of formula (II) where the various groups are as defined in the specification. The present invention also relates to the methods for their preparation, antimicrobial composition, antimicrobial gel containing these oligomers and/or polymers of Formula (I) and (II), and uses of these oligomers and/or polymers in the treatment of a microbial infection or disease.

1,3-dipolar compound bearing an imidazole functional group

In a 1,3-dipolar compound of formula Q-A-B, Q comprises a dipole containing at least and preferably one nitrogen atom, A, which is preferably divalent, is an atom or a group of atoms connecting Q to B, and B comprises an imidazole ring. An unsaturated polymer modified by grafting the 1,3-dipolar compound is also disclosed.

Pyridyl ester containing 1,4-dihydropyridine derivatives and salts thereof and pharmaceutical composition containing the same

This invention relates to a novel 1,4-dihydropyridine derivative of the formula STR1 wherein R2 is pyridyl, or a salt thereof. These compounds have a vasodilating activity and a platelet aggregation inhibiting activity. Also disclosed are pharmaceutical compositions containing the same.

Vasodilating and platelet aggregation inhibiting 1,4 dihydropyridines with an imidazolyl or pyridyl containing ester

This invention relates to a 1,4-dihydropyridine derivative of the formula STR1 wherein Y represents an oxygen or sulfur atom or a vinylene group, Z represents an oxygen or sulfur atom or an alkylene group, R2 represents an imidazolyl or pyridyl group and the remaining substituents are herein defined. These compounds have a vasodilating activity and a platelet aggregation inhibiting activity.